Literature DB >> 7513727

Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process.

T W Kuijpers1, M Raleigh, T Kavanagh, H Janssen, J Calafat, D Roos, J M Harlan.   

Abstract

The fate of E-selectin expressed on TNF-activated monolayers of HUVEC was investigated by confocal laser scanning microscopy. Cytokine-activated endothelial cells internalized mAb to E-selectin in a very rapid, energy-dependent fashion. By contrast, mAb against ICAM-1 and VCAM-1 remained surface bound. The E-selectin mAb was recovered in intracellular compartments with a tubular morphology, some of which appeared to be interconnected. Cathepsin B, a ubiquitously expressed lysosomal protease, was found to co-localize in these structures. Functional specificity of E-selectin-internalization was observed upon addition of the fluorescent SLex-oligosaccharide to the activated HUVEC monolayers. Uptake into the same E-selectin-positive compartments was observed, whereas the control oligosaccharide Lex was not internalized at all. The process of internalization was found to be unaffected by most inhibitors of protein kinase C, cAMP-dependent PKA, or protein tyrosine kinase activity. Whereas cytochalasin B preincubation of HUVEC failed to inhibit the internalization process, colchicine and vinblastine, reagents that interfere with the metabolism of tubulin, prevented the formation of the elongated structures in which E-selectin would normally be internalized. Concomitantly, the expression of E-selectin at the cell surface was significantly increased.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513727

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Enhanced accumulation of sialyl Lewis X-carboxymethylpullulan conjugate in acute inflammatory lesion.

Authors:  K Horie; M Sakagami; K Kuramochi; K Hanasaki; H Hamana; T Ito
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

2.  Cellular handling of a dexamethasone-anti-E-selectin immunoconjugate by activated endothelial cells: comparison with free dexamethasone.

Authors:  Robbert J Kok; Maaike Everts; Sigridur A Asgeirsdóttir; Dirk K F Meijer; Grietje Molema
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

Review 3.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

Review 4.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

5.  Imaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopy.

Authors:  Judith M Runnels; Parisa Zamiri; Joel A Spencer; Isreal Veilleux; Xunbin Wei; Alexei Bogdanov; Charles P Lin
Journal:  Mol Imaging       Date:  2006 Jan-Mar       Impact factor: 4.488

Review 6.  Selectin-carbohydrate interactions during inflammation and metastasis.

Authors:  R P McEver
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

7.  Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils.

Authors:  B N Cronstein; Y Molad; J Reibman; E Balakhane; R I Levin; G Weissmann
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

8.  Lipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein.

Authors:  K Huang; D M Fishwild; H M Wu; R L Dedrick
Journal:  Inflammation       Date:  1995-06       Impact factor: 4.092

Review 9.  Targeted delivery of therapeutics to endothelium.

Authors:  Eric Simone; Bi-Sen Ding; Vladimir Muzykantov
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

10.  Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting.

Authors:  Aman P Mann; Anoma Somasunderam; René Nieves-Alicea; Xin Li; Austin Hu; Anil K Sood; Mauro Ferrari; David G Gorenstein; Takemi Tanaka
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.